首页> 外文OA文献 >Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2

【2h】

Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2

机译：临床前药代动力学，Interpecies缩放和TTAC-0001的临床试验的药代动力学，一种针对血管内皮生长因子2的全人单克隆抗体2

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Weon Sup Lee; Sang Ryeol Shim; Seon Young Lee; Jin San Yoo; Sung Kweon Cho;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2 [J] . Weon Sup Lee, Sang Ryeol Shim, Seon Young Lee, Drug Design, Development and Therapy . 2018,第4期

机译：TTAC-0001的第一阶段临床试验的临床前药代动力学，物种间定标和药代动力学，TTAC-0001是针对血管内皮生长因子2的完全人单克隆抗体
2. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. [J] . Lin YS, Nguyen C, Mendoza JL, The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 1999,第1期

机译：针对血管内皮生长因子的人源化单克隆抗体的临床前药代动力学，种间缩放和组织分布。
3. Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors [J] . Su Jin Lee, Seon Young Lee, Weon Sup Lee, Investigational new drugs. . 2017,第6期

机译：Tanibirumab的I阶段试验和药代动力学研究，难治性固体肿瘤患者血管内皮生长因子受体2的全人单克隆抗体
4. High Throughput and Multiplexed LC-MS/MS Bioanalysis of Therapeutic Monoclonal Antibodies for Preclinical Pharmacokinetic Studies [C] . Hongyan Li, Robert Ortiz, Linh T.B. Tran, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：高通量和多重LC-MS / MS生物分析治疗单克隆抗体临床前药代动力学研究
5. Preclinical pharmacokinetic and tolerance assessment and phase I clinical trial of MU-Gold, a novel chemotherapeutic agent. [D] . Higginbotham, Mary Lynn. 2004

机译：新型化学治疗剂MU-Gold的临床前药代动力学和耐受性评估以及I期临床试验。
6. Preclinical pharmacokinetics interspecies scaling and pharmacokinetics of a Phase I clinical trial of TTAC-0001 a fully human monoclonal antibody against vascular endothelial growth factor 2 [O] . Weon Sup Lee, Sang Ryeol Shim, Seon Young Lee, 2018

机译：TTAC-0001的第一阶段临床试验的临床前药代动力学物种间定标和药代动力学TTAC-0001是针对血管内皮生长因子2的完全人单克隆抗体
7. Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors [O] . 2017

机译：Tanibirumab（一种抗血管内皮生长因子受体2的全人类单克隆抗体）的I期试验和药代动力学研究在难治性实体瘤患者中的应用

Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2

著录项

相似文献

相关主题

期刊订阅